5% Uses in Confidentiality Clause

Confidentiality from Stock Purchase Agreement

This Stock Purchase Agreement (this "Agreement"), dated as of March 7, 2016, is entered into among the parties listed on Exhibit A-1 hereto (each, a "Seller" and collectively, the "Sellers") and EyeGate Pharmaceuticals, Inc., a Delaware corporation ("Buyer").

Confidentiality. From and after the Closing, each Seller shall, and shall cause its Affiliates to, hold, and shall use its reasonable best efforts to cause its or their respective Representatives to hold, in confidence any and all information, whether written or oral, concerning the Company, except to the extent that any Seller can show that such information (a) is generally available to and known by the public through no fault of such Seller, any of its Affiliates or their respective Representatives; or (b) is lawfully acquired by such Seller, any of its Affiliates or their respective Representatives from and after the Closing from sources which are not prohibited from disclosing such information by a legal, contractual or fiduciary obligation. If any Seller or any of its Affiliates or Representatives are compelled to disclose any information by judicial or administrative process or by other requirements of Law, such Seller shall promptly notify Buyer in writing and shall disclose only that portion of such information which such Seller is advised by its counsel in writing is legally required to be disclosed, provided that such Seller shall use reasonable best efforts to obtain an appropriate protective order or other reasonable assurance that confidential treatment will be accorded such information.

Confidentiality from Redemption Agreement

Article I Definitions 1 Article II Purchase and Sale 13 Section 2.01 Basic Transaction 13 Section 2.02 Closing Payments 13 Section 2.03 Purchase Price Adjustment 13 Section 2.04 Adjustments to Purchase Price 15 Section 2.05 Payment of Purchase Price Adjustment 16 Section 2.06 Withholding Rights 17 Section 2.07 Closing 17 Section 2.08 Closing Deliveries 17 Article III Representations and Warranties of Seller 19 Section 3.01 Organization and Authority of Seller 19 Section 3.02 Organization, Authority and Qualification of the Company 19 Section 3.03 Capitalization 20

Confidentiality. From and after the Closing, Seller shall, and shall cause its Affiliates to, hold, and shall use its reasonable best efforts to cause its or their respective Representatives to hold, in confidence any and all information, whether written or oral, concerning the Company, except to the extent that Seller can show that such information (a) is generally available to and known by the public through no fault of Seller, any of its Affiliates or their respective Representatives; or (b) is lawfully acquired by Seller, any of its Affiliates or their respective Representatives from and after the Closing from sources that are not prohibited from disclosing such information by a legal, contractual or fiduciary obligation. If Seller or any of its Affiliates or their respective Representatives are compelled to disclose any information by judicial or administrative process or by other requirements of Law (including the rules and regulations of the Securities and Exchange Commission or any securities exchange upon which any securities of Seller, or any of its Affiliates are, or may later be, traded (the "Securities Requirement"), Seller shall promptly notify Buyer in writing and shall disclose only that portion of such information which Seller is advised by its counsel in writing is legally required to be disclosed, provided that (other than with respect to information disclosed in connection with the Securities Requirements) Seller shall use reasonable best efforts to obtain an appropriate protective order or other reasonable assurance that confidential treatment will be accorded such information.

Confidentiality from Restated Limited Liability Company Agreement

THIS SIXTH AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT (this "Agreement") of Trilogy Investors, LLC (the "Company") is made and entered into as of December 1, 2015 (the "Effective Date"), by and among Trilogy Real Estate Investment Trust, a Maryland statutory trust (the "Investor"), Trilogy Management Services, LLC (the "EIK Manager"), the parties identified as "Management Holders" on the signature pages hereto (each, together with its Permitted Transferees and successors, a "Management Holder") and each Person subsequently admitted as a member of the Company in accordance with the terms hereof (such Persons, the Management Holders, the EIK Manager and the Investor are herein collectively referred to as "Members" and each individually as a "Member"). The Company is organized under the Delaware Limited Liability Company Act, 6 Del.C. SS 18-101, et seq. (the "Act"). Capitalized terms used herein are defined in Article 2 hereof or as elsewhere provided herein.

Confidentiality. Each party hereto agrees that the provisions of this Agreement, all understandings, agreements and other arrangements between and among the parties, and all other non-public information received from or otherwise relating to, the Company and the Company Assets (the "Confidential Information") shall be confidential, and shall not be disclosed or otherwise released to any other Person (other than another party hereto), without the written consent of the Board. The obligations of the parties hereunder shall not apply: (a) so long as such Persons agree to maintain the confidential nature thereof, to a Member's actual or prospective (i) financing sources, (ii) purchasers or assignees, (iii) partners and (iv) investors; (b) to legal counsel, accountants and other professional advisors to a Member, so long as such Persons agree to maintain the confidential nature thereof; (c) to any disclosure pursuant to the order of any court or administrative agency or in any pending legal or administrative proceeding, to the extent necessary in support of motions, filings, or other proceedings in court as required to be undertaken pursuant to this Agreement, or otherwise as required by applicable law, provided that any party is given a reasonable opportunity to obtain a protective order in connection with such disclosure; (d) in connection with reporting of Community portfolio based performance and other Community portfolio information in filings with the Securities and Exchange Commission by a Member or its direct or indirect equity holders; (e) in connection with reporting requirements in filings with the Securities and Exchange Commission by a Member and its direct or indirect equity holders, which filings may include publication of such Member's or its direct or indirect equity holders' audited financial statements; (f) to any information to the extent that such information is, or has become, publicly known through circumstances not involving a breach of this Agreement; and (g) to disclosures in compliance with any filing requirements, regulations or other requirements of, or upon the request or demand of, any stock exchange (or other similar entity) on which a Member's (or the direct or indirect equity holder(s) thereof) shares (or other equity interests) are listed, or of any other governmental authority having jurisdiction over such Member. Notwithstanding anything to the contrary in this Agreement, the provisions of this Section 10.3 shall survive until the earlier of: (x) a Member's ceasing to be a member of the Company for any reason for a period of one (1) year, and (y) the dissolution and/or termination of the Company.

Confidentiality from License Agreement

This License Agreement (this "Agreement") is dated as of September 9, 2015 (the "Effective Date") by and between The Children's Hospital of Philadelphia, a non-profit entity organized and existing under the laws of the Commonwealth of Pennsylvania ("CHOP"), and neuroFix, LLC, a limited liability company organized under the laws of the State of Delaware ("Licensee"). CHOP and Licensee may be referred to herein as a "Party" or, collectively, as "Parties".

Confidentiality. Until the end of the five (5) year period beginning on the Closing Date (the "Restricted Period"), each of the Legacy Stockholders and the Equityholders shall, and shall take action to direct their counsel, accountants, financial advisors and lenders to: (a) keep all Proprietary Information of the Legacy Corporation, the Company, and Purchaser and their respective Affiliates confidential and not to disclose or reveal any such Proprietary Information to any Person other than its Affiliates and Representatives, including counsel, accountants and financial advisors who otherwise need to know such Proprietary Information; and (b) not to use such Proprietary Information for any purpose other than: (i) to the extent necessary to obtain any of the Consents required hereunder; or (ii) to enforce such Party's rights and remedies under this Agreement.

Confidentiality from Amended and Restated Executive Employment

This Amended and Restated Executive Employment Agreement (the "Agreement") by and between Albert Tylis ("Executive") and NorthStar Asset Management Group Inc. (the "Company"), dated August 5, 2015, shall be effective as of August 5, 2015 (the "Amendment Effective Date"), and shall amend and restate the Executive Employment Agreement by and among Executive, the Company and NorthStar Realty Finance Corp. ("NRF") dated June 30, 2014 (the "Prior Agreement"), which was effective as of June 30, 2014 (the "Effective Date").

Confidentiality. Each party to this Agreement shall keep strictly confidential the terms of this Agreement, provided, that (i) either party to this Agreement may disclose the terms of this Agreement with the prior written consent of the other party, (ii) either party to this Agreement may disclose the terms of this Agreement to the extent necessary to comply with law or legal process, in which event the disclosing party shall notify the other party to this Agreement as promptly as practicable (and, if possible, prior to making such disclosure), (iii) either party to this Agreement may disclose the terms of this Agreement to outside counsel, underwriters and accountants and (iv) the Company may disclose the terms of this Agreement in public filings with the Securities and Exchange Commission or other regulatory agencies, without notice to Executive, to the extent that it believes such disclosure to be prudent, necessary or required by applicable law in connection with the operation of the business of the Company and shall have the right to file a copy of this Agreement with such regulating agencies, it being understood that if this Agreement is so disclosed or filed, Executive shall thereafter be released from his obligation in respect of this Section 8.

Confidentiality from Asset Purchase Agreement

This Asset Purchase Agreement (this "Agreement"), dated as of May 8, 2015, is entered into between HUDSON GLOBAL, INC., a Delaware corporation ("Parent"), Hudson Global Resources Management, Inc., a Pennsylvania corporation ("Seller"), and MASTECH, INC., a Pennsylvania corporation ("Buyer").

Confidentiality. From and after the Closing, Seller shall, and shall cause its Affiliates to, hold, and shall use its commercially reasonable efforts to cause its or their respective Representatives to hold, in confidence any and all information, whether written or oral, concerning the Business, except to the extent that Seller can show that such information is generally available to and known by the public through no fault of Seller, any of its Affiliates or their respective Representatives. If Seller or any of its Affiliates or their respective Representatives are compelled to disclose any information by judicial or administrative process or by other requirements of Law, Seller shall promptly notify Buyer in writing and shall disclose only that portion of such information which Seller is advised by its counsel in writing is legally required to be disclosed, provided, that Seller shall use commercially reasonable efforts to obtain an appropriate protective order or other reasonable assurance that confidential treatment will be accorded such information at Buyer's sole cost and expense.

Confidentiality from Asset Purchase Agreement

THIS ASSET PURCHASE AGREEMENT (this "Agreement"), dated as of April 17, 2015 (the "Closing Date"), is made and entered into by and among (a) Jefferson Acquisition, LLC, a Kansas limited liability company and a wholly owned subsidiary of Hooper Wellness, LLC (the "Buyer"), (b) Hooper Holmes, Inc., a New York corporation ("Buyer Parent"), (c) Hooper Wellness, LLC, a Kansas limited liability company and a wholly owned subsidiary of Buyer Parent ("Hooper Wellness") (d) Accountable Health Solutions, Inc., an Indiana corporation (the "Seller"), and (e) Accountable Health, Inc., a Delaware corporation ("Shareholder").

Confidentiality. j) Any information provided to or obtained by the Parties in connection with the transactions contemplated by this Agreement will be subject to the Non-Disclosure Agreement, and shall be held by the Parties in accordance with, and be subject to the terms of, the Non-Disclosure Agreement.(k) The Parties agree to be bound by and comply with the provisions set forth in the Non-Disclosure Agreement as if such provisions were set forth herein, and such provisions are hereby incorporated herein by reference.

Confidentiality from Indemnification Agreement

This INDEMNIFICATION AGREEMENT is made as of the date set forth below (the Agreement) by and between The Madison Square Garden Company, a Delaware corporation (the Company), and (Indemnitee).

Confidentiality. Except as required by law or as otherwise becomes public (other than in violation of this Agreement) or as communicated to Indemnitees counsel or to Indemnitees or the Companys insurer, in seeking indemnification or reimbursement or payment of Expenses hereunder, Indemnitee agrees to keep confidential any information that arises in connection with this Agreement, including but not limited to, claims for indemnification or payment or reimbursement of Expenses, amounts paid or payable under this Agreement and any communications between the Indemnitee and the Company.

Confidentiality from Stock Purchase Agreement by and Among

This Stock Purchase Agreement (this Agreement), dated as of February 3, 2015, is entered into by and among Nuverra Environmental Solutions, Inc., a Delaware corporation (Seller), Heckmann Environmental Services, Inc., a Delaware corporation (Holdco), Thermo Fluids Inc., a Delaware corporation (the Company and, together with Seller and Holdco, the Seller Parties), and Safety-Kleen, Inc., a Delaware corporation (Buyer).

Confidentiality. From and after the Closing, there parties hereto shall, and shall cause their respective Affiliates to, hold, and shall use their commercially reasonable efforts to cause their respective Representatives to hold, in confidence any and all information, whether written or oral, concerning the Company and Holdco, except to the extent that the parties can show that such information (a) is generally available to and known by the public through no fault of such disclosing party, any of its Affiliates or their respective Representatives; or (b) is lawfully acquired by the disclosing party, any of their respective Affiliates or Representatives from and after the Closing from sources which are not prohibited from disclosing such information by a legal, contractual or fiduciary obligation. If any party hereto or any of their respective Affiliates or Representatives are compelled to disclose any information by judicial or administrative process or by other requirements of Law, such disclosing party shall promptly notify the other parties in writing and shall disclose only that portion of such information which such disclosing party is advised by its counsel in writing is legally required to be disclosed, provided that such disclosing party shall use commercially reasonable efforts to obtain an appropriate protective order or other reasonable assurance that confidential treatment will be accorded such information. Notwithstanding the foregoing, the parties hereto acknowledge and agree that the Confidentiality Agreement is, and shall remain, in full force and effect regardless of whether this Agreement is terminated prior to the Closing.

Confidentiality from Support Agreement

This Nomination and Support Agreement (this "Agreement", dated November 18, 2014 (the "Effective Date"), is between John H. Lewis ("Lewis"), Osmium Partners, LLC ("Osmium Partners"), Osmium Capital, LP ("Fund I"), Osmium Capital II, LP ("Fund II"), Osmium Spartan, LP ("Fund III"), Osmium Diamond, LP (Fund IV"), and Osmium Special Opportunity Fund, LP ("Fund V"), and Rosetta Stone Inc. (the "Company"). Fund I, Fund II, Fund III, Fund IV, and "Fund V", may be each referred to herein as a "Fund" and collectively as the "Funds". The Funds, Osmium Partners and Lewis, may be each referred to herein as an "Osmium Party" and collectively as the "Osmium Parties"). The Osmium Parties and the Company may be each referred to herein as a "Party" and, collectively, as the "Parties".

Confidentiality. The Osmium Parties understand and agree that as a condition to Mr. Hass becoming a director of the Company, Mr. Hass was required to sign the Director Agreement and that Mr. Hass may not provide any nonpublic information concerning the Company to any Osmium Party or any other Third Party without the Company's prior written consent and each Osmium Party agrees not to (a) cause or request Mr. Hass to breach the Director Agreement or (b) receive any nonpublic information concerning the Company from Mr. Hass. - 6 -